Moreover, comparison of the genes listed in Table 3 and Table 4 with the Ca2+-signaling proteins listed in Table 1 as potential targets for treatment of HCC indicates that many potential Ca2+-signaling targets are also mutated or under- or overexpressed in HCC. Here, PROS1 is linked to hepatocellular carcinoma.